Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Catalyst Pharmaceutical Partners, Inc.    CPRX   US14888U1016

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/24/2014 09/25/2014 09/26/2014 09/29/2014 09/30/2014 Date
2.92(c) 2.89(c) 2.98(c) 2.99(c) 3.32(c) Last
1 330 285 985 161 964 441 3 324 861 15 516 794 Volume
+3.18% -1.03% +3.11% +0.34% +11.04% Change
More quotes
Company
Catalyst Pharmaceutical Partners, Inc. is a development-stage specialty pharmaceutical company, which focuses on the development and commercialization of prescription drugs targeting addiction and diseases of the central nervous system with a focus on the treatment of drug addiction and... 
Surperformance© rating of Catalyst Pharmaceutical Pa
Trading Rating : Investor Rating : -
More about the company
Chart CATALYST PHARMACEUTICAL PA
Duration : Period :
Catalyst Pharmaceutical Pa Technical Analysis Chart | CPRX | US14888U1016 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 -
EBIT 2014 -13,9 M
Net income 2014 -13,9 M
Debt 2014 -
Yield 2014 -
Sales 2015 -
EBIT 2015 -16,3 M
Net income 2015 -15,9 M
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 0
Capi. / Sales 2015 0
Capitalization 201 M
More Financials
Latest news on CATALYST PHARMACEUTICAL PA
3h agoDJMARKET SNAPSHOT : U.S. Stocks Limp Into October
9h agoDJMARKET SNAPSHOT : Weak Housing Data Helps Push U.S. Stocks Lower
12h agoDJMARKET SNAPSHOT : U.S. Stocks: Futures Up Ahead Of Home Prices, Consumer Confide..
13h agoDJMARKET SNAPSHOT : U.S. Stocks: Futures Up Ahead Of Home Prices, Consumer Confide..
18h agoDJMARKET SNAPSHOT : U.S. Stocks Rebound; Dow Flat Over Month
1d ago CATALYST PHARMACEUTICAL PARTNERS : Pharmaceuticals Announces Positive Top-Line P..
09/04 CATALYST PHARMACEUTICAL PARTNERS : Pharmaceuticals Appoints David D. Muth as Exe..
09/03 CATALYST PHARMACEUTICAL PARTNERS : to Present at Rodman & Renshaw's 16th Annual ..
09/02 CATALYST PHARMACEUTICAL PARTNERS : Initiates Phase 1(b) Safety and Tolerance Stu..
08/15 CATALYST PHARMACEUTICAL PARTNERS : Announces Second Quarter 2014 Financial Resul..
08/14 CATALYST PHARMACEUTICAL PARTNERS : Announces Second Quarter 2014 Financial Resul..
08/11 CATALYST PHARMACEUTICAL PARTNERS : Provides Updates on Progress of Phase 3 Firda..
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF